A. Wettergren

1.9k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

A. Wettergren is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, A. Wettergren has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Epidemiology. Recurrent topics in A. Wettergren's work include Diabetes Treatment and Management (7 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). A. Wettergren is often cited by papers focused on Diabetes Treatment and Management (7 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). A. Wettergren collaborates with scholars based in Denmark. A. Wettergren's co-authors include Jens J. Holst, Cathrine Ørskov, John Christiansen, Birgit Schjoldager, Poul Erik Mortensen, John Myhre, Morten Wøjdemann, Preben Olund Kirkegaard, F. Stadil and Søren Meisner and has published in prestigious journals such as Diabetes, Gut and Diseases of the Colon & Rectum.

In The Last Decade

A. Wettergren

18 papers receiving 1.5k citations

Hit Papers

Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastr... 1993 2026 2004 2015 1993 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
    1993 544 citations A. Wettergren, Birgit Schjoldager et al. Digestive Diseases and Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wettergren Denmark 14 931 664 290 266 253 18 1.5k
A P Savage United Kingdom 16 164 0.2× 455 0.7× 227 0.8× 229 0.9× 241 1.0× 27 1.2k
Maria S. Svane Denmark 21 768 0.8× 763 1.1× 295 1.0× 707 2.7× 203 0.8× 53 1.6k
Marzieh Salehi United States 21 1.0k 1.1× 1.3k 1.9× 242 0.8× 577 2.2× 103 0.4× 58 1.8k
K. B. Lauritsen Denmark 14 303 0.3× 332 0.5× 116 0.4× 134 0.5× 88 0.3× 38 733
Urd Kielgast Denmark 13 933 1.0× 980 1.5× 239 0.8× 480 1.8× 182 0.7× 23 1.4k
A. Schafmayer Germany 17 234 0.3× 573 0.9× 118 0.4× 73 0.3× 69 0.3× 71 1.0k
J. C. Thompson United States 19 115 0.1× 371 0.6× 283 1.0× 79 0.3× 41 0.2× 45 956
J. Ardill United Kingdom 22 211 0.2× 811 1.2× 169 0.6× 130 0.5× 26 0.1× 45 1.8k
Antoine Makdissi United States 18 1.0k 1.1× 442 0.7× 264 0.9× 171 0.6× 42 0.2× 31 1.4k
S. Strobel United States 15 1.0k 1.1× 677 1.0× 276 1.0× 275 1.0× 172 0.7× 16 1.4k

Countries citing papers authored by A. Wettergren

Since Specialization
Citations

This map shows the geographic impact of A. Wettergren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wettergren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wettergren more than expected).

Fields of papers citing papers by A. Wettergren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wettergren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wettergren. The network helps show where A. Wettergren may publish in the future.

Co-authorship network of co-authors of A. Wettergren

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wettergren. A scholar is included among the top collaborators of A. Wettergren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wettergren. A. Wettergren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Plamboeck, Astrid, Simon Veedfald, Carolyn F. Deacon, et al.. (2012). Reduced incretin effect in truncally vagotomized subjects. Regulatory Peptides. 177. S29–S30. 1 indexed citations
2.
Plamboeck, Astrid, Simon Veedfald, Carolyn F. Deacon, et al.. (2012). The effect of GLP-1 on food intake is lost in trunkally vagotomized subjects. Regulatory Peptides. 177. S30–S30. 1 indexed citations
3.
Rappeport, Eli D, Annika Loft, Anne Kiil Berthelsen, et al.. (2007). Contrast-enhanced FDG-PET/CT vs. spio-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiologica. 48(4). 369–378. 98 indexed citations
4.
Wettergren, A., et al.. (2004). Glucagon‐like peptide‐2 inhibits antral emptying in man, but is not as potent as glucagon‐like peptide‐1. Scandinavian Journal of Gastroenterology. 39(4). 353–358. 90 indexed citations
5.
Wettergren, A.. (2001). Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.. PubMed. 48(1). 19–28. 3 indexed citations
6.
Wettergren, A., Morten Wøjdemann, & Jens J. Holst. (1998). The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated Primary Metabolite GLP-1 (9-36)amide. Peptides. 19(5). 877–882. 58 indexed citations
7.
Wettergren, A., Morten Wøjdemann, Søren Meisner, F. Stadil, & Jens J. Holst. (1997). The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.. Gut. 40(5). 597–601. 119 indexed citations
8.
Wettergren, A., et al.. (1997). Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man. Scandinavian Journal of Gastroenterology. 32(6). 552–555. 56 indexed citations
9.
Ørskov, Cathrine, A. Wettergren, & Jens J. Holst. (1996). Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day. Scandinavian Journal of Gastroenterology. 31(7). 665–670. 227 indexed citations
10.
Wettergren, A., et al.. (1995). Social and sexual function following ileal pouch-anal anastomosis. Diseases of the Colon & Rectum. 38(3). 286–289. 85 indexed citations
11.
Wettergren, A., et al.. (1995). Closure of rectal stump after colectomy for acute colitis. International Journal of Colorectal Disease. 10(4). 197–199. 23 indexed citations
12.
Wettergren, A., et al.. (1994). Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man. Scandinavian Journal of Gastroenterology. 29(6). 501–505. 103 indexed citations
13.
Wettergren, A., Birgit Schjoldager, Poul Erik Mortensen, et al.. (1993). Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man. Digestive Diseases and Sciences. 38(4). 665–673. 544 indexed citations breakdown →
14.
Wettergren, A., et al.. (1993). Complications after J-pouch ileoanal anastomosis: stapled compared with handsewn anastomosis.. PubMed. 159(2). 121–4. 19 indexed citations
15.
Ørskov, Cathrine, A. Wettergren, & Jens J. Holst. (1993). Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes. 42(5). 658–661. 52 indexed citations
16.
Ørskov, Cathrine, et al.. (1992). Structure of human GLP-1(glucagon-like peptide-1) containing peptides. Regulatory Peptides. 40(2). 223–223. 4 indexed citations
17.
Wettergren, A., et al.. (1991). Risk of Recurrence and Reoperation after Resection for Ileocolic Crohn's Disease. Scandinavian Journal of Gastroenterology. 26(12). 1319–1322. 45 indexed citations
18.
Wettergren, A., et al.. (1991). Granulomas of the Appendix: Is It Crohn's Disease?. Scandinavian Journal of Gastroenterology. 26(9). 961–964. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A P Savage Breakdown of academic impact, for papers by Maria S. Svane Breakdown of academic impact, for papers by Marzieh Salehi Breakdown of academic impact, for papers by K. B. Lauritsen Breakdown of academic impact, for papers by Urd Kielgast Breakdown of academic impact, for papers by A. Schafmayer Breakdown of academic impact, for papers by J. C. Thompson Breakdown of academic impact, for papers by J. Ardill Breakdown of academic impact, for papers by Antoine Makdissi Breakdown of academic impact, for papers by S. Strobel
Rankless by CCL
2026